Live Analyst Rating Changes 19067 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Cherilyn Radbourne
TD

Cherilyn Radbourne

TD Cowen
Wall Street Analyst
★★★★☆
#923
on 13Foresight · ranked by our own returns
64%
Success Rate
+6.6%
Average Return
23 of 36 calls profitable · -1.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 64% of Cherilyn Radbourne's ratings turned a profit when each position was held for 2 year — averaging +6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

50 Buy 12 Hold 0 Sell
Cherilyn's Stock Coverage 15 ratings · 2026-08-06
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
TSE:ATS
ATS Corporation
 Aug 03, 2026 BUY Strong Buy
+22.7% avg upside
11 analysts
$49.00
24.65% Upside
 · ·
BIP
Brookfield Infrastructure
 Jul 31, 2026 BUY Strong Buy
+11.4% avg upside
13 analysts
$57.00
43.73% Upside
 -6.0% ·
TSE:CP
Canadian Pacific Kansas City
 Jul 30, 2026 HOLD Strong Buy
+8.3% avg upside
36 analysts
$134.00
4.73% Upside
 +0.0% ·
TSE:TIH
Toromont Industries
 Jul 29, 2026 BUY Buy
-24.4% avg upside
14 analysts
$264.00
16.41% Upside
 +4.5% ·
TSE:BAM
Brookfield Asset Management Ltd. Class A
 Jul 27, 2026 BUY Buy
+10.2% avg upside
19 analysts
$98.22
33.06% Upside
 +0.1% ·
TSE:CNR
Canadian National Railway
 Jul 24, 2026 BUY Buy
-3.2% avg upside
36 analysts
$205.00
14.74% Upside
 -2.6% ·
TSE:FTT
Finning International
 Jun 10, 2026 BUY Strong Buy
-17.1% avg upside
12 analysts
$120.00
21.46% Upside
 +0.1% ·
TSE:BN
Brookfield Corporation
 May 19, 2026 BUY Strong Buy
+17.9% avg upside
15 analysts
$84.19
34.88% Upside
 -3.1% ·
ORCL
Oracle
 Sep 16, 2025 BUY Strong Buy
+52.7% avg upside
70 analysts
$375.00
159.76% Upside
 -52.4% ·
CSX
CSX
 Jan 26, 2023 HOLD Strong Buy
-5.3% avg upside
35 analysts
$35.00
31.52% Downside
 +11.5% ·
UNP
Union Pacific
 Jan 25, 2023 HOLD Strong Buy
-2.4% avg upside
35 analysts
$225.00
23.81% Downside
 +30.3% ·
NSC
Norfolk Southern
 Oct 13, 2022 HOLD Buy
-9.4% avg upside
32 analysts
$245.00
28.32% Downside
 +21.7% ·
TSE:MX
Methanex
 Jun 18, 2022 BUY Buy
+16.0% avg upside
16 analysts
$82.79
13.72% Upside
 +28.9% ·
TSE:RBA
RB Global
 Jan 06, 2022 HOLD Strong Buy
+6.5% avg upside
18 analysts
 — +19.4% ·
TSE:CNQ
Canadian Natural
 Dec 12, 2020 BUY Buy
-1.5% avg upside
29 analysts
$34.00
45.89% Downside
 +169.7% ·
🔒 10 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Cherilyn Radbourne — Frequently Asked Questions
How accurate are Cherilyn Radbourne's stock ratings?
Based on the calls 13Foresight could measure, about 61% of Cherilyn's ratings were profitable over a one-year hold, with an average return of +2.3% per rating, or -1.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Cherilyn ranked on 13Foresight?
Cherilyn Radbourne is currently ranked #923 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Cherilyn cover?
Cherilyn most recently has ratings on TSE:ATS, BIP, TSE:CP, TSE:TIH, TSE:BAM, TSE:CNR, TSE:FTT, TSE:BN, ORCL, CSX, UNP, NSC and 3 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.